IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
ELI:IBS - Euronext Lisbon - PTIBS0AM0008 - Common Stock - Currency: EUR
Overall IBS gets a fundamental rating of 4 out of 10. We evaluated IBS against 58 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and the financial health of IBS get a neutral evaluation. Nothing too spectacular is happening here. IBS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
IBS had positive earnings in the past year.
IBS had a positive operating cash flow in the past year.
IBS had positive earnings in 4 of the past 5 years.
Each year in the past 5 years IBS had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 1.16%, IBS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
IBS has a Return On Equity (2.54%) which is in line with its industry peers.
The Return On Invested Capital of IBS (3.13%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for IBS is significantly below the industry average of 10.78%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 2.54% | ||
| ROIC | 3.13% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
1.3 Margins
IBS has a Profit Margin of 1.74%. This is comparable to the rest of the industry: IBS outperforms 48.28% of its industry peers.
IBS's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 4.61%, IBS perfoms like the industry average, outperforming 48.28% of the companies in the same industry.
IBS's Operating Margin has declined in the last couple of years.
The Gross Margin of IBS (49.59%) is comparable to the rest of the industry.
IBS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.61% | ||
| PM (TTM) | 1.74% | ||
| GM | 49.59% |
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBS is destroying value.
The number of shares outstanding for IBS has been reduced compared to 1 year ago.
IBS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for IBS is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.96 indicates that IBS is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.96, IBS is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
IBS has a debt to FCF ratio of 6.53. This is a slightly negative value and a sign of low solvency as IBS would need 6.53 years to pay back of all of its debts.
IBS has a Debt to FCF ratio (6.53) which is in line with its industry peers.
A Debt/Equity ratio of 0.69 indicates that IBS is somewhat dependend on debt financing.
IBS's Debt to Equity ratio of 0.69 is fine compared to the rest of the industry. IBS outperforms 70.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 6.53 | ||
| Altman-Z | 1.96 |
ROIC/WACC0.51
WACC6.19%
2.3 Liquidity
A Current Ratio of 1.09 indicates that IBS should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.09, IBS is doing good in the industry, outperforming 68.97% of the companies in the same industry.
IBS has a Quick Ratio of 1.01. This is a normal value and indicates that IBS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.01, IBS is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
The earnings per share for IBS have decreased strongly by -47.78% in the last year.
Measured over the past years, IBS shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.23% on average per year.
The Revenue has grown by 15.22% in the past year. This is quite good.
Measured over the past years, IBS shows a decrease in Revenue. The Revenue has been decreasing by -0.46% on average per year.
EPS 1Y (TTM)-47.78%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%-314.5%
Revenue 1Y (TTM)15.22%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%17.83%
3.2 Future
IBS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.05% yearly.
Based on estimates for the next years, IBS will show a quite strong growth in Revenue. The Revenue will grow by 8.19% on average per year.
EPS Next Y32.28%
EPS Next 2Y25.49%
EPS Next 3Y23.64%
EPS Next 5Y26.05%
Revenue Next Year7.14%
Revenue Next 2Y7.41%
Revenue Next 3Y6.44%
Revenue Next 5Y8.19%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 50.00 indicates a quite expensive valuation of IBS.
Compared to the rest of the industry, the Price/Earnings ratio of IBS is on the same level as its industry peers.
When comparing the Price/Earnings ratio of IBS to the average of the S&P500 Index (27.30), we can say IBS is valued expensively.
A Price/Forward Earnings ratio of 19.80 indicates a rather expensive valuation of IBS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IBS indicates a somewhat cheap valuation: IBS is cheaper than 63.79% of the companies listed in the same industry.
IBS's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.76.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50 | ||
| Fwd PE | 19.8 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, IBS is valued a bit cheaper than 79.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.67 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as IBS's earnings are expected to grow with 23.64% in the coming years.
PEG (NY)1.55
PEG (5Y)N/A
EPS Next 2Y25.49%
EPS Next 3Y23.64%
5. Dividend
5.1 Amount
IBS has a Yearly Dividend Yield of 7.17%, which is a nice return.
Compared to an average industry Dividend Yield of 3.15, IBS pays a better dividend. On top of this IBS pays more dividend than 98.28% of the companies listed in the same industry.
IBS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.17% |
5.2 History
The dividend of IBS is nicely growing with an annual growth rate of 48.65%!
Dividend Growth(5Y)48.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
242.99% of the earnings are spent on dividend by IBS. This is not a sustainable payout ratio.
IBS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP242.99%
EPS Next 2Y25.49%
EPS Next 3Y23.64%
ELI:IBS (7/11/2025, 7:00:00 PM)
10
+0.26 (+2.67%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners24.17%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap415.10M
Analysts83.33
Price Target13.31 (33.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.17% |
Yearly Dividend0.49
Dividend Growth(5Y)48.65%
DP242.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)11.84%
Min Revenue beat(2)11.28%
Max Revenue beat(2)12.41%
Revenue beat(4)4
Avg Revenue beat(4)8.54%
Min Revenue beat(4)0.18%
Max Revenue beat(4)12.41%
Revenue beat(8)7
Avg Revenue beat(8)6.47%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.51%
PT rev (3m)10.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50 | ||
| Fwd PE | 19.8 | ||
| P/S | 0.84 | ||
| P/FCF | 8.67 | ||
| P/OCF | 5.26 | ||
| P/B | 1.23 | ||
| P/tB | 1.74 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.2
EY2%
EPS(NY)0.51
Fwd EY5.05%
FCF(TTM)1.15
FCFY11.53%
OCF(TTM)1.9
OCFY19%
SpS11.85
BVpS8.12
TBVpS5.73
PEG (NY)1.55
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 2.54% | ||
| ROCE | 4.01% | ||
| ROIC | 3.13% | ||
| ROICexc | 4.09% | ||
| ROICexgc | 5.28% | ||
| OM | 4.61% | ||
| PM (TTM) | 1.74% | ||
| GM | 49.59% | ||
| FCFM | 9.73% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
ROICexc(3y)5.24%
ROICexc(5y)N/A
ROICexgc(3y)7.05%
ROICexgc(5y)N/A
ROCE(3y)4.21%
ROCE(5y)N/A
ROICexcg growth 3Y-24.94%
ROICexcg growth 5Y-3.32%
ROICexc growth 3Y-22.88%
ROICexc growth 5Y-3.24%
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
F-Score6
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 6.53 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 6.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 560.26% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 1.96 |
F-Score6
WACC6.19%
ROIC/WACC0.51
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.76%
Cap/Sales(5y)11.65%
Profit Quality(3y)200.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.78%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%-314.5%
EPS Next Y32.28%
EPS Next 2Y25.49%
EPS Next 3Y23.64%
EPS Next 5Y26.05%
Revenue 1Y (TTM)15.22%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%17.83%
Revenue Next Year7.14%
Revenue Next 2Y7.41%
Revenue Next 3Y6.44%
Revenue Next 5Y8.19%
EBIT growth 1Y0.48%
EBIT growth 3Y-20.54%
EBIT growth 5Y-7.19%
EBIT Next Year399.89%
EBIT Next 3Y91.9%
EBIT Next 5Y58.09%
FCF growth 1Y-27.17%
FCF growth 3Y-0.14%
FCF growth 5Y-9.32%
OCF growth 1Y-26.24%
OCF growth 3Y1.82%
OCF growth 5Y-6.35%